Act-Hib 30 mcg

ACT-HIB 30 MCG is a vaccine kit designed to protect against Haemophilus influenzae type b (Hib) infections. This intramuscular injection is manufactured by Sanofi Pasteur Limited in Canada.

ACT-HIB 30 MCG is used to prevent invasive diseases caused by Haemophilus influenzae type b (Hib), such as meningitis and sepsis. It is typically administered to infants and children as part of their routine immunization schedule. The vaccine works by stimulating the body's immune response to develop protection against Hib bacteria.

Common effects of ACT-HIB 30 MCG may include mild redness, swelling, or tenderness at the injection site. Some individuals might experience a low-grade fever, irritability, or loss of appetite. These effects are usually mild and temporary.

ACT-HIB 30 MCG should be administered by a healthcare professional. It is important to inform the healthcare provider about any allergies, particularly to yeast or any component of the vaccine. Individuals with a history of severe allergic reactions to a previous dose of ACT-HIB or any of its components should avoid this vaccine.

ACT-HIB 30 MCG may interact with other vaccines or medications. It is generally safe to administer simultaneously with other vaccines, but specific guidelines should be followed. Always consult a healthcare provider before combining ACT-HIB with other treatments.